CapitalG co-led a series C round for Everlaw, developer of a legal information search product, which has now secured more than $96m in total.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Zumper pumps in another $60m
The Marcus & Millichap and Axel Springer-backed rental real estate portal has completed its series D round to bring its overall equity funding to more than $150m.
InSightec locks in Koch for $150m series F
The ultrasound surgery system developer is targeting $150m at a $1.3bn post-money valuation, with Koch Disruptive Technologies supplying $100m.
Arkin makes a mark with $140m fund
Phoenix Group and Migdal have supplied capital for Arkin Bio-Ventures II, which investment firm Arkin Holdings will use to invest in 10 to 12 drug developers.
Pager calls in $33m
Horizon Blue Cross Blue Shield of New Jersey took part in an equity and debt round for medical communication app developer led by Health Catalyst Capital.
Pex steps up for Dubset acquisition
Rhapsody and MediaNet have both exited music copyright management platform Dubset in an acquisition by peer Pex likely to have been priced between $25m and $50m.
Biotalys broadens series C round
Bio-fungicide and pesticide developer Biotalys has added $11.3m to a Globalchem-backed round now totalling $50.9m.
Hailo salutes corporates in $60m series B
ABB Technology Ventures and NEC took part in a $60m series B round that will support the AI processor developer’s global expansion efforts.
Ordr pushes funding forward to $50m
The IoT security software provider has raised $50m in total, Kaiser Permanente Ventures and Mayo Clinic having boosted its series B round to a likely $33.5m.
Transphorm shapes reverse merger
The semiconductor technology producer has gone public through a reverse merger with penny stock company Peninsula Acquisition and received $21.5m from investors including Marelli.
Netlify sets out $53m series C
The app development software provider increased its overall funding to more than $97m in a series C round that did not include existing corporate investor Bloomberg Beta.
Five counts up $41m
Sistema and Direct Line participated in a $41m series B round for Five, which is currently trialling its autonomous driving technology in London.
Novartis helps plant $100m in Pliant
Pliant Therapeutics has attracted $100m in a series C round led by Novartis, four years after it was founded to commercialise UC San Francisco research into fibrosis treatment.
Rigetti rigs up $71m round
Bloomberg-backed quantum computing technology developer Rigetti Computing has raised an initial $71m for a funding round with an $83.9m targeted close.